Latest Cancer News ⁽⁸⁾

The mRNA vaccine, which first showed its hand during the COVID pandemic, is now being pinned high hopes for solving cancer. The American drugmaker Moderna is ambitiously developing vaccines against a variety of cancers and other diseases, and claims results within five years. Moderna's chief…

Johnson & Johnson's baby powder and other talc-containing products have been taken to court over possible carcinogenicity. On April 4, 2023, J&J announced plans to pay $8.9 billion over the next 25 years to compensate consumers, settling lawsuits over the possible carcinogenicity of its baby…

The Journal of the National Cancer Institute recently published a research report. After tracking 33,947 women aged 35 to 74 for 11 consecutive years, researchers found that 378 women who frequently used chemical hair straighteners were diagnosed with uterine cancer. The study showed that women…

PD-1 immunotherapy has developed rapidly in recent years. As a new therapy for tumor diseases, it is deeply welcomed by clinicians and patients; oncologists, cancer patients, and their families all place great expectations on it, hoping to use immunotherapy to solve the cancer problem. But…

On April 8, 2022, Professor Cai Shang's group at the School of Life Sciences, Westlake University, China, published a paper in the internationally authoritative journal Cell, once again confirming the existence of bacteria inside tumor cells and demonstrating for the first time that bacteria unique…

A spokeswoman for the World Health Organization's Department of Noncommunicable Diseases, Ilbawi, recently told the media that, according to data released by the WHO in December 2020, 19.3 million people worldwide were diagnosed with cancer in 2020 and 10 million died of cancer. Cancer has…

On May 2, 2018, I was to take a train from Hangzhou Station back to Beijing. A gastric cancer patient whom I had followed for nearly two years came to Hangzhou Station to see me. We found an empty seat at the KFC in Hangzhou…

Original headline: Fudan University sells anti-tumor drug patent to a U.S. company for a record US$65 million. On March 15, Fudan University and the U.S. company HUYA (Huya Bioscience) reached an agreement in Shanghai: Professor Yang Qing of Fudan's School of Life Sciences licensed, for…